306 related articles for article (PubMed ID: 21795366)
21. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis.
Tang S; Huang G; Liu J; Liu T; Treven L; Song S; Zhang C; Pan L; Zhang T
Eur J Radiol; 2011 Apr; 78(1):142-50. PubMed ID: 19854016
[TBL] [Abstract][Full Text] [Related]
23. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
Huet P; Burg S; Le Guludec D; Hyafil F; Buvat I
J Nucl Med; 2015 Apr; 56(4):552-9. PubMed ID: 25722452
[TBL] [Abstract][Full Text] [Related]
24. Positron emission tomography in the prediction of inflammation in children with human immunodeficiency virus related bronchiectasis.
Masekela R; Gongxeka H; Green RJ; Sathekge M
Hell J Nucl Med; 2012; 15(1):23-7. PubMed ID: 22413108
[TBL] [Abstract][Full Text] [Related]
25. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
26. 18-Fluoro-deoxyglucose-PET/Computed Tomography in Infection and Aseptic Inflammatory Disorders: Value to Patient Management.
Basu S; Ranade R
PET Clin; 2015 Jul; 10(3):431-9. PubMed ID: 26099677
[TBL] [Abstract][Full Text] [Related]
27. Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
Qiao W; Zhao J; Wang C; Wang T; Xing Y
Hematology; 2010 Feb; 15(1):21-7. PubMed ID: 20132658
[TBL] [Abstract][Full Text] [Related]
28. The predictive value of C-reactive protein and erythrocyte sedimentation rate for 18F-FDG PET/CT outcome in patients with fever and inflammation of unknown origin.
Balink H; Veeger NJ; Bennink RJ; Slart RH; Holleman F; van Eck-Smit BL; Verberne HJ
Nucl Med Commun; 2015 Jun; 36(6):604-9. PubMed ID: 25738560
[TBL] [Abstract][Full Text] [Related]
29. Placental-site trophoblastic tumor and fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography.
Çerçi SS; Erdemoglu E; Bozkurt KK; Yalçn Y; Erdemoglu E
Hell J Nucl Med; 2015; 18(3):264-7. PubMed ID: 26574698
[TBL] [Abstract][Full Text] [Related]
30. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
31. Thorax: normal and benign pathologic patterns in FDG-PET/CT imaging.
Wachsmann JW; Gerbaudo VH
PET Clin; 2014 Apr; 9(2):147-68. PubMed ID: 25030279
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities.
Basu S; Chryssikos T; Moghadam-Kia S; Zhuang H; Torigian DA; Alavi A
Semin Nucl Med; 2009 Jan; 39(1):36-51. PubMed ID: 19038599
[TBL] [Abstract][Full Text] [Related]
33. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
[TBL] [Abstract][Full Text] [Related]
34. Serial changes of (18)F-FDG PET/CT findings in ischiopubic synchondrosis: comparison with contrast-enhanced MRI.
Tsuji K; Tsuchida T; Kosaka N; Tanizawa A; Kimura H
Hell J Nucl Med; 2015; 18(1):66-7. PubMed ID: 25679077
[TBL] [Abstract][Full Text] [Related]
35. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143
[TBL] [Abstract][Full Text] [Related]
36. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
Jadvar H; Henderson RW; Conti PS
J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
[TBL] [Abstract][Full Text] [Related]
37. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
Zhang X; Wu F; Han P
Hell J Nucl Med; 2014; 17(3):177-83. PubMed ID: 25526754
[TBL] [Abstract][Full Text] [Related]
38. Scan-rescan measurement repeatability of
Robson PM; Kaufman A; Pruzan A; Dweck MR; Trivieri MG; Abgral R; Karakatsanis NA; Brunner PM; Guttman E; Fayad ZA; Mani V
J Nucl Cardiol; 2022 Aug; 29(4):1660-1670. PubMed ID: 34046803
[TBL] [Abstract][Full Text] [Related]
39. FDG-PET/CT in Infectious and Inflammatory Diseases.
Hess S; Hansson SH; Pedersen KT; Basu S; Høilund-Carlsen PF
PET Clin; 2014 Oct; 9(4):497-519, vi-vii. PubMed ID: 26050949
[TBL] [Abstract][Full Text] [Related]
40. Fever of unknown origin: the role of 18F-FDG PET/CT.
Keidar Z; Gurman-Balbir A; Gaitini D; Israel O
J Nucl Med; 2008 Dec; 49(12):1980-5. PubMed ID: 18997040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]